New Delhi: Serum Institute of India’s CEO Adar Poonawalla said, that SII is planning to launch a vaccine for those below the age of 18 “down to the age of three” within the next six months to protect from COVID-19.
The CEO was speaking at the 27th CII Partnership Summit 2021 via a virtual conference, In which Adar Poonawalla asserted that Covovax, is under trial and will be available soon. Adar added, “We are going to be launching a vaccine in six months for children down to the age of three. Covishield is not recommended or approved in people below the age of 18 so that’s why Covovax is under trials and has shown excellent data down to the age group of 3.”
On the concern of Omicron. Adar added, “The impact of Omicron is yet to be seen in children, they have so far not been impacted very badly with this strain. “I think their body, cells, and their lungs recover better and fortunately the panic isn’t there for children.” Adar asserted.
Whereas, on the Booster doses. Adar said The Data is provided to Govt. and regulatory bodies. They will decide. Earlier on 3rd December, Union Health Minister Mansukh Mandaviya Answered in Parliament that the Government will make a decision based on recommendations from its two key expert groups on vaccine administration.